Can gastritis symptoms be evaluated in clinical trials? An overview of treatment of gastritis, nonulcer dyspepsia and Campylobacter-associated gastritis.
We carried out a review of the literature on Campylobacter pylori-associated gastritis and nonulcer dyspepsia (NUD) to determine whether or not symptoms related to these conditions can be measured reliably and whether or not any study to date has shown that treatment alters symptoms. Search strategies consisted of online Medline searching, a forward search of three articles using the Science Citation Index, a manual search of five gastroenterological journals, and a fully recursive search of cited references. Inclusion and quality criteria were applied to all retrieved studies. Nine of 23 studies did not fulfill the inclusion criteria. Of the 14 studies analyzed, two measured symptoms reliably. Neither showed a therapeutic benefit on symptoms. The difficulties encountered in conducting such studies and the methods of recording symptoms reliably are discussed. We conclude that to date, no treatment is of proven benefit in the relief of symptoms associated with C. pylori gastritis and NUD.
Veldhuyzen van Zanten
S J
SJ
Division of Gastroenterology, McMaster University, Hamilton, Ontario, Canada.
Tytgat
K M
KM
Jalali
S
S
Goodacre
R L
RL
Hunt
R H
RH
D002169:Campylobacter Infections / Q000188:drug therapy*; D004415:Dyspepsia / Q000188:drug therapy*; D005756:Gastritis / Q000188:drug therapy* / Q000209:etiology; D006305:Health Status Indicators; D006801:Humans; D016032:Randomized Controlled Trials as Topic